In 2017, the entry that became Parkinson’s Mechanism Analysis \u2014 Proof of Function #1<\/a> was written down as Invent Deposition #3526<\/strong>:<\/p>\n “Electronic muscle pulse therapy for atrophy patients\u00a0help me walk? some organic \/ some post organic measure electronic muscle pulse therapy for atrophy patients step 3 super infomercial for medical if i saw it on tv it has to be real disabled tendon repair and extensions step 2 chicken cat transfer alternate cartilage transplant organic fiber optic nerve conductors step 1 non evasive neurological where do you have trouble and electronic pulse for prolonged wheel chair patients,.”— © 2017 Christopher Gabriel Brown<\/span><\/p>\n<\/blockquote>\n The 2017 entry tackled the motor-control problem at the muscle-and-nerve layer \u2014 patients who need help with movement, and a closed-loop electronic pulse therapy concept. The Proof of Function moves that framing upstream to the dopaminergic pathway: a mechanism-analysis grid traces candidate pathway nodes, scores them against the closed-loop rubric used across the cure-discovery portfolio, and packages the result for partner-team evaluation. The redaction layer lets a reviewer work with the IP without exposing the AES-encrypted source archive. Patent-pending; design targets only \u2014 no warranted clinical outcome.<\/p>\n\n
What changed between 2017 and the product on the shelf<\/h2>\n
Where it sits in the four-step framework<\/h2>\n
\n